Tarek M.A. Abdel-Fatah

High Frequency of Coexistence of Columnar Cell Lesions, Lobular Neoplasia, and Low Grade Ductal Carcinoma In Situ With Invasive Tubular Carcinoma and Invasive Lobular Carcinoma

Tarek M.A. Abdel-Fatah, Desmond G. Powe, Zsolt Hodi et al. · The American Journal of Surgical Pathology · 2007 · 273 citations

Invasive Tubular Carcinoma, Tumoral Pathology, Breast Oncology +13

SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis

Tarek M.A. Abdel-Fatah, Devika Agarwal, Dongxu Liu et al. · The Lancet Oncology · 2016 · 102 citations · Full text

Prognostic Biomarkers, Breast Oncology, Oncology +11

Targeting XRCC1 Deficiency in Breast Cancer for Personalized Therapy

Rebeka Sultana, Tarek M.A. Abdel-Fatah, Rachel Abbotts et al. · Cancer Research · 2012 · 96 citations

Breast Oncology, Medicine, Xrcc1 Expression +14

Untangling the ATR‐CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer

Tarek M.A. Abdel-Fatah, Fiona K. Middleton, Arvind Arora et al. · Molecular Oncology · 2014 · 84 citations · Full text

Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells

Rebeka Sultana, Tarek M.A. Abdel-Fatah, Christina J. Perry et al. · PLoS ONE · 2013 · 83 citations · Full text